• Home
  • Investor Relations
  • Traders
    • Hot Now
    • Past Winners
    • Potential Winners
    • OTC Stocks
  • About
  • Contact
  • Let’s Get Started
Let's Get Started

TLSA stock

Tiziana Life Sciences (NASDAQ: TLSA): Major MS Trial Success Puts Intranasal Foralumab in the Spotlight as Global Pharma Talks Begin

Tiziana Life Sciences (NASDAQ: TLSA): Major MS Trial Success Puts Intranasal Foralumab in the Spotlight as Global Pharma Talks Begin

Nov 1, 2026

Positive Phase 2a Result The Phase 21...

read more
Tiziana Life Sciences (NASDAQ: TLSA): 5 Clinical Milestones Behind Its Foralumab Research in 2026

Tiziana Life Sciences (NASDAQ: TLSA): 5 Clinical Milestones Behind Its Foralumab Research in 2026

Oct 30, 2026

November 2, 2026 | Clinical Trial...

read more
  • Follow
  • Follow
  • Follow

We Are Small Cap Exclusive

Email

[email protected]

Phone

843.567.1234

Call Us Now
Navigation

Home

Hot Now

Past Winners

Potential Winners

Quick Links

About

Investor Relations

Contact

Disclaimer